Lixing Xu

1.4k total citations
45 papers, 1.2k citations indexed

About

Lixing Xu is a scholar working on Molecular Biology, Biomedical Engineering and Neurology. According to data from OpenAlex, Lixing Xu has authored 45 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Biomedical Engineering and 6 papers in Neurology. Recurrent topics in Lixing Xu's work include Neuroinflammation and Neurodegeneration Mechanisms (4 papers), Neurological Disease Mechanisms and Treatments (4 papers) and Tryptophan and brain disorders (4 papers). Lixing Xu is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (4 papers), Neurological Disease Mechanisms and Treatments (4 papers) and Tryptophan and brain disorders (4 papers). Lixing Xu collaborates with scholars based in China, Australia and South Korea. Lixing Xu's co-authors include Zhanqiang Ma, Xueyang Deng, Shiping Ma, Paul B. Rothman, Siqi Wang, Jing Su, Ruyi Zhang, Shiping Ma, Ruixiang Yan and Qiang Fu and has published in prestigious journals such as Food Chemistry, Biochemical and Biophysical Research Communications and Journal of Controlled Release.

In The Last Decade

Lixing Xu

39 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lixing Xu China 17 342 208 186 184 138 45 1.2k
Amos A. Fatokun United Kingdom 20 743 2.2× 99 0.5× 167 0.9× 87 0.5× 140 1.0× 60 1.7k
Yu Long China 23 477 1.4× 237 1.1× 98 0.5× 140 0.8× 320 2.3× 50 1.6k
Qing Zhu China 23 742 2.2× 88 0.4× 166 0.9× 206 1.1× 151 1.1× 95 1.7k
Chuwen Li China 28 777 2.3× 208 1.0× 97 0.5× 162 0.9× 130 0.9× 79 1.9k
Feng Xiao China 28 849 2.5× 141 0.7× 245 1.3× 131 0.7× 92 0.7× 62 1.9k
Daiying Zuo China 28 950 2.8× 76 0.4× 121 0.7× 182 1.0× 89 0.6× 104 2.5k
Zhiqin Gao China 25 643 1.9× 55 0.3× 94 0.5× 172 0.9× 138 1.0× 77 1.6k

Countries citing papers authored by Lixing Xu

Since Specialization
Citations

This map shows the geographic impact of Lixing Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lixing Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lixing Xu more than expected).

Fields of papers citing papers by Lixing Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lixing Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lixing Xu. The network helps show where Lixing Xu may publish in the future.

Co-authorship network of co-authors of Lixing Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Lixing Xu. A scholar is included among the top collaborators of Lixing Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lixing Xu. Lixing Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Lixing, Shanshan Li, Xiangyang Qian, et al.. (2025). Poly-lysine-modified recombinant protein nanocages for effective delivery of small activating RNA. Journal of Controlled Release. 382. 113638–113638. 3 indexed citations
3.
Cai, Liangliang, Shanshan Li, Cheng Wan, et al.. (2025). Nasal-to-brain siRNA delivery based on trace amine associated receptor for improving cognitive function. Journal of Controlled Release. 388(Pt 2). 114373–114373.
4.
Xu, Lixing, Jack Kit‐Chung Ng, Winston Wing‐Shing Fung, et al.. (2025). Circulating Muscle Markers for Sarcopenia in Peritoneal Dialysis. International Journal of Nephrology. 2025(1). 8817404–8817404.
5.
Xu, Lixing, Jie Yang, Xinyu Cao, et al.. (2024). Sequential system based on ferritin delivery system and cell therapy for modulating the pathological microenvironment and promoting recovery. International Journal of Pharmaceutics. 664. 124607–124607.
7.
Cai, Liangliang, Lixing Xu, Kai Shen, et al.. (2024). Sophorae tonkinensis radix polysaccharide attenuates acetaminophen-induced liver injury by regulating the miR-140-5p-related antioxidant mechanism. Journal of Traditional and Complementary Medicine. 14(4). 467–476. 2 indexed citations
8.
Xu, Lixing, Jing Qin, Xiaofei Ma, et al.. (2024). Chitosan-based self-healing thermosensitive hydrogel loaded with siHMGB1 for treatment of rheumatoid arthritis via macrophage repolarization. International Journal of Biological Macromolecules. 282(Pt 4). 137102–137102. 7 indexed citations
9.
Xu, Lixing, et al.. (2023). pH-Responsive Hydrogel as a Potential Oral Delivery System of Baicalin for Prolonging Gastroprotective Activity. Pharmaceutics. 15(1). 257–257. 16 indexed citations
11.
Li, Shanshan, et al.. (2023). Neurotoxicity of melittin: Role of mitochondrial oxidative phosphorylation system in synaptic plasticity dysfunction. Toxicology. 497-498. 153628–153628. 10 indexed citations
12.
Pan, Xiuhua, et al.. (2021). Mitochondria-targeted curcumin loaded CTPP–PEG–PCL self-assembled micelles for improving liver fibrosis therapy. RSC Advances. 11(10). 5348–5360. 14 indexed citations
13.
Xu, Lixing, Haiqin Huang, Tianqing Liu, Tao Yang, & Xuan Yi. (2021). Exposure to X-rays Causes Depression-like Behaviors in Mice via HMGB1-mediated Pyroptosis. Neuroscience. 481. 99–110. 16 indexed citations
14.
Zhang, Ruyi, Zhongxuan Ma, Kai‐Li Liu, et al.. (2019). Baicalin exerts antidepressant effects through Akt/FOXG1 pathway promoting neuronal differentiation and survival. Life Sciences. 221. 241–248. 25 indexed citations
15.
Xu, Lixing, Jing Su, Liting Guo, et al.. (2019). Modulation of LPA1 receptor-mediated neuronal apoptosis by Saikosaponin-d: A target involved in depression. Neuropharmacology. 155. 150–161. 40 indexed citations
16.
Li, Shanshan, Xiaoxu Sun, Lixing Xu, et al.. (2017). Baicalin attenuates in vivo and in vitro hyperglycemia-exacerbated ischemia/reperfusion injury by regulating mitochondrial function in a manner dependent on AMPK. European Journal of Pharmacology. 815. 118–126. 102 indexed citations
17.
Sun, Xiaoxu, Shanshan Li, Lixing Xu, et al.. (2017). Paeoniflorin ameliorates cognitive dysfunction via regulating SOCS2/IRS-1 pathway in diabetic rats. Physiology & Behavior. 174. 162–169. 41 indexed citations
18.
Zhang, Na, et al.. (2016). Red and blue LED weak light irradiation maintaining quality of cherry tomatoes during cold storage.. Nongye gongcheng xuebao. 32(9). 248–254. 4 indexed citations
19.
Xu, Lixing, et al.. (2014). Perillaldehyde attenuates cerebral ischemia–reperfusion injury-triggered overexpression of inflammatory cytokines via modulating Akt/JNK pathway in the rat brain cortex. Biochemical and Biophysical Research Communications. 454(1). 65–70. 55 indexed citations
20.
Xu, Lixing, et al.. (2009). Surface modified Fe3O4 nanoparticles as a protein delivery vehicle. Colloids and Surfaces A Physicochemical and Engineering Aspects. 350(1-3). 8–12. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026